Connection

SASIREKHA RAMANI to Antiviral Agents

This is a "connection" page, showing publications SASIREKHA RAMANI has written about Antiviral Agents.
Connection Strength

1.087
  1. 2'-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids. J Virol. 2025 Feb 25; 99(2):e0093824.
    View in: PubMed
    Score: 0.604
  2. Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. J Virol. 2025 Feb 25; 99(2):e0175724.
    View in: PubMed
    Score: 0.151
  3. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development. J Infect Dis. 2023 10 03; 228(Suppl 5):S337-S354.
    View in: PubMed
    Score: 0.138
  4. Norovirus Protease Structure and Antivirals Development. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.121
  5. BTP2 restricts Tulane virus and human norovirus replication independent of store-operated calcium entry. J Virol. 2025 Jun 17; 99(6):e0044425.
    View in: PubMed
    Score: 0.039
  6. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0063623.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.